30results about How to "Definite inhibitory effect" patented technology

The invention discloses the application of sanguinarine in inhibiting the growth of multidrug-resistant Enterobacter hallii. Ceftiaquine, azithromycin and nalidixic acid have good killing effect on multidrug-resistant Enterobacter hallii in vitro, and can inhibit the growth of multidrug-resistant Enterobacter hallii, and the minimum inhibitory concentration is 0.12 mg / mL, the lowest The bactericidal concentration is 0.24 mg / mL, and the invention proposes the inhibitory effect of sanguinarine on multidrug-resistant Enterobacter hallii, which has wide application value in the fields of medicine and the like.

The present invention provides proto-opioid alkaloids and pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or racemic mixture salts, polymorphs, optical isomers, racemates, and Application of Corydalis Corydalis and its extracts containing proto-opioid alkaloids, Xia Wu and its extracts, Boluohui and its extracts in the preparation of drugs for inhibiting P-gp function. The present invention also provides proto-opioid alkaloids and pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or racemic mixture salts, polymorphs, optical isomers, and racemates, And the application of Corydalis Corydalis and its extracts containing original opioid alkaloids, Xia Wu and its extracts, Boluohui and its extracts in the preparation of drugs for adjuvant tumor treatment, the adjuvant tumor treatment refers to the reversal of the combination of P ‑Gp high expression related tumor multidrug resistance, synergistic antitumor drugs.

The invention discloses a bacteriostatic and antiviral preparation taking kidney bean phytohemagglutinin as a major ingredient, and belongs to the technical field of medicines. The bacteriostatic andantiviral preparation consists of the following active components according to relative parts by weight: 0.1-1.0 part of the kidney bean phytohemagglutinin, 0.2-2.0 parts of one or two of stachyose and raffinose as well as one or more of the following active components: 0.1-0.5 part of povidone iodine, 0.1-0.3 part of polyhexylene biguanidine and 0.1-0.5 part of chlorhexidine; and in addition, a thickening agent, which is hydroxyethyl cellulose, is required. The bacteriostatic and antiviral preparation provided by the invention is concrete in components, and is capable of achieving quantitative control and guaranteeing the consistency and stability of overall quality; a concrete inhibitory effect can be achieved on bacteria, fungi and viruses; therefore, the bacteriostatic and antiviral preparation is relatively broad in antibacterial and antiviral ranges; and the product (the bacteriostatic and antiviral preparation), which is required to be preserved at low temperature, is long in preservation duration and convenient to use.

The invention relates to the field of preparation of antitumor drugs and especially relates to a use of Asterias rollestoni Bell extract in preparation of an antitumor drug. The Asterias rollestoni Bell extract is Asterias rollestoni Bell alcohol extract extracted from Asterias rollestoni Bell by a solvent. The solvent is a methanol aqueous solution or an ethanol aqueous solution or a mixed solution of methanol and ethanol. The Asterias rollestoni Bell extract also can be ethyl acetate extract or n-butanol extract of the Asterias rollestoni Bell alcohol extract. An experiment proves that the Asterias rollestoni Bell extract has moderate antitumor activity, and can obviously inhibit mice H22 solid tumor and mice S180 solid tumor, and especially, the ethyl acetate extract of the Asterias rollestoni Bell alcohol extract has obvious inhibition effects. Therefore, the Asterias rollestoni Bell extract can be used for treating cancers and especially for liver cancer.